Market Share, Costs of Biologic Therapies for IBD in the USA Market Share, Costs of Biologic Therapies for IBD in the USA

This study examined trends in the use of biologics for IBD, relative market share compared to other medication classes, and costs in the USA during a 9-year period.Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news